InvestorsHub Logo
Followers 58
Posts 7686
Boards Moderated 2
Alias Born 07/07/2002

Re: None

Monday, 04/20/2015 9:10:04 AM

Monday, April 20, 2015 9:10:04 AM

Post# of 465
09:03 CNDO Coronado Biosciences disclosed it has decided to no longer pursue the development of its Trichuris suis ova program (4.34 )

The Company is terminating all on-going TSO trials, including the Company's Phase 2A clinical trial of TSO in pediatric patients with autism spectrum disorder. A preliminary analysis of data from this trial failed to demonstrate any signal of activity.


Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz3Xr2CzXbF